Article info
Clinical science
Change in choroidal thickness after intravitreal aflibercept in pretreated and treatment-naive eyes for neovascular age-related macular degeneration
- Correspondence to Professor Stephan Michels, Department of Ophthalmology, City Hospital Triemli, Birmensdorferstrasse 497, Zurich 8063, Switzerland; stephan.michels{at}zuerich.ch
Citation
Change in choroidal thickness after intravitreal aflibercept in pretreated and treatment-naive eyes for neovascular age-related macular degeneration
Publication history
- Received January 14, 2015
- Revised March 18, 2015
- Accepted March 21, 2015
- First published April 15, 2015.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/